))
It’s not about THC, it’s about CBD (cannabinoids)
Archived series ("HTTP Redirect" status)
Replaced by: asfpodcast.org
When?
This feed was archived on July 14, 2018 01:43 (
Why? HTTP Redirect status. The feed permanently redirected to another series.
What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 184382220 series 99374
Content provided by Autism Science Foundation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Autism Science Foundation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Parents of children with seizures are desperate to find something that will at the very least reduce the frequency of seizures in their kids. Answers came in an unlikely place two months ago with the publication of a randomized clinical trial showing that seizures could be reduced with use of cannabinoids in kids with a condition called Dravet's Syndrome. Cannabinoids are one of the chemicals found in marijuana, and there are anecdotal reports on the use of marijuana or cannabinoids to treat autism. Unlike THC, CBD (cannabinoids) do not cause euphoria or any psychoactive effects and are used exclusively for medicinal reasons. This podcast summarizes current literature and also explains why it is so hard to study cannabinoids, including federal and state regulations and what needs to happen to open up this field of science
…
continue reading
76 episodes
Share
